Current Report Filing (8-k)
August 17 2015 - 5:02PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
Date of Report (Date of Earliest Event Reported):
|
|
August 17, 2015
|
|
DNB Financial Corporation
__________________________________________
(Exact name of registrant as specified in its charter)
|
Pennsylvania
|
1-34242
|
23-2222567
|
|
_____________________
(State or other jurisdiction
|
_____________
(Commission
|
______________
(I.R.S. Employer
|
|
of incorporation)
|
File Number)
|
Identification No.)
|
| |
|
|
|
4 Brandywine Avenue, Downingtown, Pennsylvania
|
|
19335
|
|
_________________________________
(Address of principal executive offices)
|
|
___________
(Zip Code)
|
|
Registrant’s telephone number, including area code:
|
|
(610) 269-1040
|
|
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
[ ]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01 Other Events
On August 17, 2015, William S. Latoff, Chairman and Chief Executive Officer of DNB Financial Corporation issued a letter to all employees informing them of a recently diagnosed medical condition. A copy of the letter is attached as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits. The following exhibit is furnished herewith:
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
DNB Financial Corporation
|
| |
|
|
August 17, 2015
|
By:
|
/s/ Gerald F. Sopp
|
| |
|
Name: Gerald F. Sopp
|
| |
|
Title: Chief Financial Officer and
Executive Vice President
|
DNB Financial Corporation
4 Brandywine Avenue
Downingtown, PA 19335
| |
|
|
|
|
Executive Offices
|
Tel 484.359.3151
|
Fax 484.359.3176
|
www.dnbfirst.com
|
August 17, 2015
Dear Colleagues:
I want to share with you the news that I was recently diagnosed with non-Hodgkin's lymphoma, a form of cancer that is highly treatable and curable.
My physicians have told me that during the course of my treatments, which I've recently begun, I can expect to maintain a regular presence in the office and continue to actively lead the management of our bank. When treatment does require my absence, I have complete confidence in the ability of our strong and experienced executive leadership team to direct our day-to-day operations. I also have confidence in each of you to carry on, doing your very best on behalf of our customers and shareholders.
Our Board of Directors is fully supportive of our team's approach during the period of my treatment and, as appropriate, I will keep you informed of my progress.
Thank you all very much for your kind thoughts and prayers, which are of more comfort to me than you realize.
|
Sincerely,
|
|
| |
|
 |
|
| |
|
|
William S. Latoff
|
|
|
Chairman & CEO
|
|
DNB Financial (NASDAQ:DNBF)
Historical Stock Chart
From Aug 2024 to Sep 2024
DNB Financial (NASDAQ:DNBF)
Historical Stock Chart
From Sep 2023 to Sep 2024
